Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5901 USD | +10.30% | +10.30% | +7.23% |
May. 28 | ABN Amro: private bank acquired in Germany | CF |
May. 28 | ABN Amro to buy German private bank in biggest deal since 2008 financial crisis | RE |
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The company does not generate enough profits, which is an alarming weak point.
- One of the major weak points of the company is its financial situation.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Investment Management & Fund Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+7.23% | 4.7B | - | ||
-5.14% | 113B | A- | ||
+6.90% | 99.06B | C+ | ||
+25.24% | 66.41B | C | ||
+8.26% | 63.68B | - | B+ | |
+12.60% | 43.94B | C+ | ||
+12.76% | 41.92B | A- | ||
+27.30% | 36.44B | A- | ||
+9.94% | 25.57B | B | ||
-6.87% | 21.43B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 656 Stock
- FOSU.F Stock
- Ratings Fosun International Limited